Frontiers in Immunology (Feb 2018)

Extracellular Vesicles Released from Mycobacterium tuberculosis-Infected Neutrophils Promote Macrophage Autophagy and Decrease Intracellular Mycobacterial Survival

  • Violeta D. Alvarez-Jiménez,
  • Kahiry Leyva-Paredes,
  • Mariano García-Martínez,
  • Luis Vázquez-Flores,
  • Víctor Gabriel García-Paredes,
  • Marcia Campillo-Navarro,
  • Marcia Campillo-Navarro,
  • Israel Romo-Cruz,
  • Víctor Hugo Rosales-García,
  • Víctor Hugo Rosales-García,
  • Jessica Castañeda-Casimiro,
  • Sirenia González-Pozos,
  • José Manuel Hernández,
  • Carlos Wong-Baeza,
  • Blanca Estela García-Pérez,
  • Vianney Ortiz-Navarrete,
  • Sergio Estrada-Parra,
  • Jeanet Serafín-López,
  • Isabel Wong-Baeza,
  • Rommel Chacón-Salinas,
  • Rommel Chacón-Salinas,
  • Iris Estrada-García

DOI
https://doi.org/10.3389/fimmu.2018.00272
Journal volume & issue
Vol. 9

Abstract

Read online

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (Mtb). In the lungs, macrophages and neutrophils are the first immune cells that have contact with the infecting mycobacteria. Neutrophils are phagocytic cells that kill microorganisms through several mechanisms, which include the lytic enzymes and antimicrobial peptides that are found in their lysosomes, and the production of reactive oxygen species. Neutrophils also release extracellular vesicles (EVs) (100–1,000 nm in diameter) to the extracellular milieu; these EVs consist of a lipid bilayer surrounding a hydrophilic core and participate in intercellular communication. We previously demonstrated that human neutrophils infected in vitro with Mtb H37Rv release EVs (EV-TB), but the effect of these EVs on other cells relevant for the control of Mtb infection, such as macrophages, has not been completely analyzed. In this study, we characterized the EVs produced by non-stimulated human neutrophils (EV-NS), and the EVs produced by neutrophils stimulated with an activator (PMA), a peptide derived from bacterial proteins (fMLF) or Mtb, and observed that the four EVs differed in their size. Ligands for toll-like receptor (TLR) 2/6 were detected in EV-TB, and these EVs favored a modest increase in the expression of the co-stimulatory molecules CD80, a higher expression of CD86, and the production of higher amounts of TNF-α and IL-6, and of lower amounts of TGF-β, in autologous human macrophages, compared with the other EVs. EV-TB reduced the amount of intracellular Mtb in macrophages, and increased superoxide anion production in these cells. TLR2/6 ligation and superoxide anion production are known inducers of autophagy; accordingly, we found that EV-TB induced higher expression of the autophagy-related marker LC3-II in macrophages, and the co-localization of LC3-II with Mtb inside infected macrophages. The intracellular mycobacterial load increased when autophagy was inhibited with wortmannin in these cells. In conclusion, our results demonstrate that neutrophils produce different EVs in response to diverse activators, and that EV-TB activate macrophages and promote the clearance of intracellular Mtb through early superoxide anion production and autophagy induction, which is a novel role for neutrophil-derived EVs in the immune response to Mtb.

Keywords